Clinical Trials in New York

Showing 2361-2380 of 10,830 trials

Proton Re-Irradiation for Recurrent Head and Neck Cancer

NCT03217188

The purpose of this study is to evaluate the tumor control and the side effects of using proton therapy for head and neck cancer that has come back.

Head and Neck Cancer

Memorial Sloan Kettering Cancer Center87 participantsStarted Jul 2017

Miami, Florida, United States • Basking Ridge, New Jersey, United States • Middletown, New Jersey, United States +6 more locations

COMPLETEDPhase 2< 1 mile

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

NCT04996797

The purpose of this study is to assess the safety and efficacy of tulisokibart in participants with moderately to severely active Ulcerative Colitis (UC). After the completion of the 12-week induction, all participants have the option to continue in the open-label extension for up to 170 weeks.

Ulcerative Colitis

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)178 participantsStarted Jul 2021

Mobile, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +85 more locations

Proton Re-Irradiation for Recurrent Head and Neck Cancer

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Find Trials by Condition in New York

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

OurChild: A Health IT Solution to Reduce Minority Health Disparities

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

Early Age-Related Hearing Loss Investigation (EARHLI)

Cognitive Reappraisal Training for Borderline Personality

A Study of N9 Chemotherapy in Children With Neuroblastoma

AE05ML Device for ML Hem-o-lok Polymer Clip Delivery in Laparoscopic Surgical Procedures Observational Registery Study

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

SLC13A5 Deficiency Natural History Study - United States Only

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer

A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease